NCT00613782View on ClinicalTrials.gov

Reandron in Diabetic Men Witn Low Testosterone Level

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

88

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

April 30, 2014

Conditions

Type 2 DiabetesHypogonadism

Interventions

DRUG

Reandron 1000

1000mg at 0,6,18,30 weeks

DRUG

placebo

placebo injection 0,6.18.30 weeks

Trial Locations (1)

3084

Austin Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Austin Health

OTHER_GOV

NCT00613782 - Reandron in Diabetic Men Witn Low Testosterone Level | Biotech Hunter | Biotech Hunter